THOR MEDICAL AS
Thor Medical AS is a producer and supplier of radionuclides, primarily alpha emitters, for cancer therapy. The production process requires no radiation and provides reliable, low cost supply of sought after ฮฑ-particles.
Similar Organizations
Beams
Beams is a producer of medical devices for cancerology based on the use of particles ฮฒ.
Breeze Mobility
Breeze Mobility is a growing (online and offline) mobility products retailer and wholesaler based in Sydney, Australia.
Brosmed
Brosmed is a provider of interventional vascular therapy services.
CardioStory Inc
CardioStory build a Non-Invasive Filling Pressure (NIFP) measurement and monitoring platform for heart failure patients.
Healthcare Plus Supplies
Healthcare Plus Supplies is a medical equipment supplier that provides products and services to local hospices and their patients.
Lianzhong Technology
Lianzhong Technology focuses on the production and sales of chemiluminescence immunoassay systems.
Medicons
Medicons is a wholesaler of medicines, medical equipment and therapeutic product.
MonaLisa Touch
MonaLisa Touch is a clinical laser therapy used in gynecological treatments.
Rongsheng Medical
Rongsheng Medical focuses on the field of precision internal radiation interventional therapy for cancer.
More informations about "Thor Medical AS"
About - Thor Medical
Thor Medical was founded in 2017 by Scatec Innovation AS and other shareholders of Thor Energy AS, a company dedicated to research and development on the use of Thorium. Contact Thor Medical HQ โฆSee details»
Board and Management - Thor Medical
Hassfjell holds an M.Sc. 1992 and D.Sc. 1997 in nuclear chemistry from University of Oslo (UiO). He has more than 30 yearsโ experience in nuclear and radiochemistry scientific research with โฆSee details»
Thor Medical | Alpha emitters for cancer therapy
Apr 11, 2025 The production process is based on a novel technology developed by Thor Medical that combines high efficiency and cost competitive structure with best in class environmental โฆSee details»
Thor Medical ASA - LinkedIn
Thor Medical is an emerging supplier of isotopes for targeted alpha therapies in oncology. Our proprietary production technology eliminates the need for nuclear reactors and cyclotrons, offering a ...See details»
Enabling next-generation precision cancer therapy - NTB
Thor Medical HQ Karenslyst allé 9C NO-0278 Oslo, Norway Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, for medical use in cancer therapy. Its โฆSee details»
2024 Second Half and Full-Year Results - kommunikasjon.ntb.no
Why invest in Thor Medical We are enabling next-generation precision cancer treatments 26 1 Major market opportunity The radiotherapeutics market is set to increase to USD 27bn by โฆSee details»
Thor Medical ASA (LON:0R6Y) Company Profile & Overview
Mar 4, 2025 Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and โฆSee details»
Thor Medical ASA - Cision News
Oslo, 17 August 2023: Thor Medical ASA will release its first half results on Thursday 31 August 2023 at 07:00 am (CEST). A presentation of the results followed by a Q&A session will be held โฆSee details»
News | Thor Medical
Apr 11, 2025 Thor Medical makes final investment decision for AlphaOne โ ready for commercial production in 2026. February 26, 2025. Thor Medical ASA interim and full-year โฆSee details»
Thor Medical makes final investment decision for AlphaOne
Mar 25, 2025 Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no โฆSee details»
Thor Medical - heroya-industripark.no
Thor Medical Its proprietary production technology eliminates the need for nuclear reactors and cyclotrons, offering a more efficient and environmentally sustainable approach to traditional โฆSee details»
Thor Medical AS - Crunchbase Company Profile & Funding
Jun 10, 2023 Organization. Thor Medical AS . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Thor Medical AS is a producer and โฆSee details»
Thor Medical ASA reports 2023 results - NTB
Feb 28, 2024 Thor Medical ASA, an emerging supplier of alpha-emitters for next-generation precision cancer treatment, today announced results for the second half and full year 2023. โฆSee details»
Corporate Governance - Thor Medical
Contact Thor Medical HQ. Drammensveien 167 NO-0277 Oslo, Norway Org.no: 994 297 422 MVA + 47 974 14 000 (08.00-16.00 CET) [email protected]. Design and development by .See details»
Major milestone for Thor Medical and cancer treatment
Oct 9, 2024 Sindre Hassfjell, CTO Thor Medical, explains the process for the guests. "Thorium has a half-life of 14 billion years, so we can call it a perpetual machine," he said with a smile. โฆSee details»
Thor Medical ASA reports first half 2024 results โ Pilot facility ...
Oslo, 30 August 2024: Thor Medical ASA, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, today announced results for the first half of 2024. The โฆSee details»
Reports and presentations - Thor Medical
Contact Thor Medical HQ. Drammensveien 167 NO-0277 Oslo, Norway Org.no: 994 297 422 MVA + 47 974 14 000 (08.00-16.00 CET) [email protected]. Design and development by .See details»
Thor Medical ASA interim and full-year 2024 results โ closing in on ...
Feb 26, 2025 Thor Medical ASA, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, today announced interim results and preliminary full โฆSee details»
Thor Medical capital markets update: Enabling next-generation โฆ
Nov 25, 2024 โThor Medical aims to become a world-leading supplier of alpha-emitters for cancer therapies and we have made significant progress towards realizing our ambitions this โฆSee details»
Thor Medical capital markets update: Enabling next-generation โฆ
Nov 25, 2024 Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no โฆSee details»